To explore the mechanism of interaction of hepatitis B virus (HBV) with P53 protein and its role in the hepatocarcinogenesis. Methods: HBV genome was analysed by computer program. The probe containing specific DNA-pro...To explore the mechanism of interaction of hepatitis B virus (HBV) with P53 protein and its role in the hepatocarcinogenesis. Methods: HBV genome was analysed by computer program. The probe containing specific DNA-protein binding site in HBV genome was synthesized and reacted with nuclei protein of hepatoma cell lines. Specific binding was determined by electrophoretic mobility shift assay, electrophoretic mobility supershift assay and in situ ultraviolet cross-linking assay. Co-transfection was performed by using reporter gene cat, p53 and dexamethasone inducible HBx to observe the biological functions of HBV binding to p53 protein. Results: A p53 response element binding sequence is present in HBV genome at upstream of enhancer I from 1047 to 1059 hp. This sequence is capable of binding to p53 protein and increasing accumulation of p53 protein in cells. Conclusion: The results strongly suggest that DNA-protein binding of HBV with P53 protein plays a significant role and it may be the predominant mechanism in the pathogenesis of HBV-associated hepatocellular carcinoma.展开更多
文摘To explore the mechanism of interaction of hepatitis B virus (HBV) with P53 protein and its role in the hepatocarcinogenesis. Methods: HBV genome was analysed by computer program. The probe containing specific DNA-protein binding site in HBV genome was synthesized and reacted with nuclei protein of hepatoma cell lines. Specific binding was determined by electrophoretic mobility shift assay, electrophoretic mobility supershift assay and in situ ultraviolet cross-linking assay. Co-transfection was performed by using reporter gene cat, p53 and dexamethasone inducible HBx to observe the biological functions of HBV binding to p53 protein. Results: A p53 response element binding sequence is present in HBV genome at upstream of enhancer I from 1047 to 1059 hp. This sequence is capable of binding to p53 protein and increasing accumulation of p53 protein in cells. Conclusion: The results strongly suggest that DNA-protein binding of HBV with P53 protein plays a significant role and it may be the predominant mechanism in the pathogenesis of HBV-associated hepatocellular carcinoma.
